Oltmans Curtis Gale
Officer at FULC; General Counsel at ARRAY BIOPHARMA INC
- Sold, on record
- $1.5M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Dec 15, 2025
- Form 144 notices
- 1
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- FULCFulcrum Therapeutics, Inc.Officer
- ARRAY BIOPHARMA INCGeneral Counsel
Sales by reason
0
Routine
1
Plan not stated
0
No plan
4
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- ARRAY BIOPHARMA INC75,000 shares
- FULC3,452 shares
Shares sold, every Form 4 sale on record.
Timeline
- Dec 15, 2025Unusual
Sold 25.2% of their holdings
$45k3,452 shares at $12.92
- Dec 15, 2025Notice
Filed a notice to sell 3,452 shares
$45k3,452 shares
- Feb 5, 2019Unusual
Sold 72.7% of their holdings
$800k40,000 shares at $20.00
- Jan 25, 2019Unusual
Sold 78.2% of their holdings
$253k14,029 shares at $18.00
- Jan 18, 2019Plan not stated
Sold 24.2% of their holdings
$23k1,251 shares at $18.00
- Jan 15, 2019Unusual
Sold 83.4% of their holdings
$356k19,720 shares at $18.06
6 of 6
Every transaction
Loading transactions…
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | Dec 17, 2025 | FULC | Chief Legal Officer | Form 4 sale | 3,452 | $45k | 25.2% | Unusual | SEC |
| Dec 15, 2025 | Dec 15, 2025 | FULC | Officer | Form 144 notice | 3,452 | $45k | Notice | SEC | |
| Feb 5, 2019 | Feb 7, 2019 | ARRAY BIOPHARMA INC | General Counsel | Form 4 sale | 40,000 | $800k | 72.7% | Unusual | SEC |
| Jan 25, 2019 | Jan 29, 2019 | ARRAY BIOPHARMA INC | General Counsel | Form 4 sale | 14,029 | $253k | 78.2% | Unusual | SEC |
| Jan 18, 2019 | Jan 23, 2019 | ARRAY BIOPHARMA INC | General Counsel | Form 4 sale | 1,251 | $23k | 24.2% | Plan not stated | SEC |
| Jan 15, 2019 | Jan 17, 2019 | ARRAY BIOPHARMA INC | General Counsel | Form 4 sale | 19,720 | $356k | 83.4% | Unusual | SEC |